tiprankstipranks
Immatics N.V. (IMTX)
NASDAQ:IMTX
US Market
IMTX
Immatics
RESEARCH TOOLSreports
Want to see IMTX full AI Analyst Report?

Immatics (IMTX) Stock Forecast & Price Target

338 Followers
See the Price Targets and Ratings of:

IMTX Analyst Ratings

Strong Buy
8Ratings
Strong Buy
8 Buy
0 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Immatics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IMTX Stock 12 Month Forecast

Average Price Target

$19.03
▲(70.35% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Immatics in the last 3 months. The average price target is $19.03 with a high forecast of $25.00 and a low forecast of $12.20. The average price target represents a 70.35% change from the last price of $11.17.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","15":"$15","26":"$26","9.5":"$9.5","20.5":"$20.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.02857142857143,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$19.03</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$12.20</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,9.5,15,20.5,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.79,11.883076923076922,12.976153846153846,14.069230769230767,15.162307692307692,16.255384615384614,17.348461538461535,18.44153846153846,19.534615384615385,20.627692307692307,21.72076923076923,22.813846153846153,23.906923076923075,{"y":25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.79,11.423736263736263,12.057472527472527,12.69120879120879,13.324945054945054,13.958681318681318,14.592417582417582,15.226153846153846,15.85989010989011,16.493626373626373,17.127362637362637,17.7610989010989,18.394835164835165,{"y":19.02857142857143,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.79,10.898461538461538,11.006923076923076,11.115384615384615,11.223846153846154,11.332307692307692,11.44076923076923,11.549230769230768,11.657692307692306,11.766153846153845,11.874615384615383,11.983076923076922,12.09153846153846,{"y":12.2,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.01,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.01,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.54,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.48,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.34,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.19,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.26,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.5,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.99,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.99,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.01,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.79,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$25.00Average Price Target$19.03Lowest Price Target$12.20
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Chardan Capital Analyst forecast on IMTX
Geulah Livshits
Chardan Capital
Chardan Capital
$25
Buy
123.81%
Upside
Reiterated
05/19/26
Chardan Capital Reaffirms Their Buy Rating on Immatics (IMTX)
Mizuho Securities Analyst forecast on IMTX
Graig Suvannavejh
Mizuho Securities
Mizuho Securities
$25
Buy
123.81%
Upside
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Immatics (NASDAQ: IMTX) and Cormedix (NASDAQ: CRMD)
Bank of America Securities Analyst forecast on IMTX
Alec Stranahan
Bank of America Securities
Bank of America Securities
$17
Buy
52.19%
Upside
Reiterated
05/14/26
Bank of America Securities Reaffirms Their Buy Rating on Immatics (IMTX)
TD Cowen Analyst forecast on IMTX
Nicholas Lorusso
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/12/26
Analysts' Top Healthcare Picks: Olema Pharmaceuticals (OLMA), Structure Therapeutics, Inc. Sponsored ADR (GPCR)
Guggenheim Analyst forecast on IMTX
Paul Jeng
Guggenheim
Guggenheim
$19
Buy
70.10%
Upside
Reiterated
05/12/26
Guggenheim Reaffirms Their Buy Rating on Immatics (IMTX)
Goldman Sachs Analyst forecast on IMTX
Rajan Sharma
Goldman Sachs
Goldman Sachs
$11→$12.2
Buy
9.22%
Upside
Assigned
05/12/26
Immatics (IMTX) Gets a Buy from Goldman Sachs
Jefferies Analyst forecast on IMTX
Faisal Khurshid
Jefferies
Jefferies
$18
Buy
61.15%
Upside
Initiated
03/15/26
Analysts Offer Insights on Healthcare Companies: LifeMD (NASDAQ: LFMD), Immatics (NASDAQ: IMTX) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)
Leerink Partners Analyst forecast on IMTX
Jonathan Chang
Leerink Partners
Leerink Partners
$17
Buy
52.19%
Upside
Reiterated
03/06/26
Analysts' Top Healthcare Picks: Climb Bio (CLYM), Ibio (IBIO)
Clear Street Analyst forecast on IMTX
Kaveri Pohlman
Clear Street
Clear Street
$18
Buy
61.15%
Upside
Reiterated
12/11/25
Clear Street Reaffirms Their Buy Rating on Immatics (IMTX)
Cantor Fitzgerald Analyst forecast on IMTX
Eric Schmidt FCA
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Reiterated
06/02/25
Cantor Fitzgerald Keeps Their Buy Rating on Immatics (IMTX)
Deutsche Bank Analyst forecast on IMTX
James Shin
Deutsche Bank
Deutsche Bank
$10
Buy
-10.47%
Downside
Initiated
05/28/25
Immatics (IMTX) Receives a Buy from Deutsche Bank
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Chardan Capital Analyst forecast on IMTX
Geulah Livshits
Chardan Capital
Chardan Capital
$25
Buy
123.81%
Upside
Reiterated
05/19/26
Chardan Capital Reaffirms Their Buy Rating on Immatics (IMTX)
Mizuho Securities Analyst forecast on IMTX
Graig Suvannavejh
Mizuho Securities
Mizuho Securities
$25
Buy
123.81%
Upside
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Immatics (NASDAQ: IMTX) and Cormedix (NASDAQ: CRMD)
Bank of America Securities Analyst forecast on IMTX
Alec Stranahan
Bank of America Securities
Bank of America Securities
$17
Buy
52.19%
Upside
Reiterated
05/14/26
Bank of America Securities Reaffirms Their Buy Rating on Immatics (IMTX)
TD Cowen Analyst forecast on IMTX
Nicholas Lorusso
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/12/26
Analysts' Top Healthcare Picks: Olema Pharmaceuticals (OLMA), Structure Therapeutics, Inc. Sponsored ADR (GPCR)
Guggenheim Analyst forecast on IMTX
Paul Jeng
Guggenheim
Guggenheim
$19
Buy
70.10%
Upside
Reiterated
05/12/26
Guggenheim Reaffirms Their Buy Rating on Immatics (IMTX)
Goldman Sachs Analyst forecast on IMTX
Rajan Sharma
Goldman Sachs
Goldman Sachs
$11→$12.2
Buy
9.22%
Upside
Assigned
05/12/26
Immatics (IMTX) Gets a Buy from Goldman Sachs
Jefferies Analyst forecast on IMTX
Faisal Khurshid
Jefferies
Jefferies
$18
Buy
61.15%
Upside
Initiated
03/15/26
Analysts Offer Insights on Healthcare Companies: LifeMD (NASDAQ: LFMD), Immatics (NASDAQ: IMTX) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)
Leerink Partners Analyst forecast on IMTX
Jonathan Chang
Leerink Partners
Leerink Partners
$17
Buy
52.19%
Upside
Reiterated
03/06/26
Analysts' Top Healthcare Picks: Climb Bio (CLYM), Ibio (IBIO)
Clear Street Analyst forecast on IMTX
Kaveri Pohlman
Clear Street
Clear Street
$18
Buy
61.15%
Upside
Reiterated
12/11/25
Clear Street Reaffirms Their Buy Rating on Immatics (IMTX)
Cantor Fitzgerald Analyst forecast on IMTX
Eric Schmidt FCA
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Reiterated
06/02/25
Cantor Fitzgerald Keeps Their Buy Rating on Immatics (IMTX)
Deutsche Bank Analyst forecast on IMTX
James Shin
Deutsche Bank
Deutsche Bank
$10
Buy
-10.47%
Downside
Initiated
05/28/25
Immatics (IMTX) Receives a Buy from Deutsche Bank
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Immatics

3 Months
Jonathan ChangLeerink Partners
Success Rate
15/30 ratings generated profit
50%
Average Return
+3.64%
Copying Jonathan Chang's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +3.64% per trade.
1 Year
Graig SuvannavejhMizuho Securities
Success Rate
12/19 ratings generated profit
63%
Average Return
+1.06%
Copying Graig Suvannavejh's trades and holding each position for 1 Year would result in 63.16% of your transactions generating a profit, with an average return of +1.06% per trade.
2 Years
Alec StranahanBank of America Securities
Success Rate
7/13 ratings generated profit
54%
Average Return
+25.29%
Copying Alec Stranahan's trades and holding each position for 2 Years would result in 53.85% of your transactions generating a profit, with an average return of +25.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IMTX Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
6
5
10
9
12
Buy
3
1
0
1
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
6
10
10
15
In the current month, IMTX has received 15 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IMTX average Analyst price target in the past 3 months is 19.03.
Each month's total comprises the sum of three months' worth of ratings.

IMTX Financial Forecast

IMTX Earnings Forecast

Next quarter’s earnings estimate for IMTX is -$0.49 with a range of -$0.58 to -$0.34. The previous quarter’s EPS was -$0.50. IMTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IMTX has Performed in-line its overall industry.
Next quarter’s earnings estimate for IMTX is -$0.49 with a range of -$0.58 to -$0.34. The previous quarter’s EPS was -$0.50. IMTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IMTX has Performed in-line its overall industry.

IMTX Sales Forecast

Next quarter’s sales forecast for IMTX is $11.93M with a range of $5.81M to $15.75M. The previous quarter’s sales results were $8.91M. IMTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IMTX has Performed in-line its overall industry.
Next quarter’s sales forecast for IMTX is $11.93M with a range of $5.81M to $15.75M. The previous quarter’s sales results were $8.91M. IMTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IMTX has Performed in-line its overall industry.

IMTX Stock Forecast FAQ

What is IMTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Immatics N.V.’s 12-month average price target is 19.03.
    What is IMTX’s upside potential, based on the analysts’ average price target?
    Immatics N.V. has 70.35% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is IMTX a Buy, Sell or Hold?
          Immatics N.V. has a consensus rating of Strong Buy which is based on 8 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Immatics N.V.’s price target?
            The average price target for Immatics N.V. is 19.03. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $25.00 ,the lowest forecast is $12.20. The average price target represents 70.35% Increase from the current price of $11.17.
              What do analysts say about Immatics N.V.?
              Immatics N.V.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of IMTX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.